193 related articles for article (PubMed ID: 22635525)
1. A new in vivo model to test anti-tuberculosis drugs using fluorescence imaging.
Zelmer A; Carroll P; Andreu N; Hagens K; Mahlo J; Redinger N; Robertson BD; Wiles S; Ward TH; Parish T; Ripoll J; Bancroft GJ; Schaible UE
J Antimicrob Chemother; 2012 Aug; 67(8):1948-60. PubMed ID: 22635525
[TBL] [Abstract][Full Text] [Related]
2. Rapid in vivo assessment of drug efficacy against Mycobacterium tuberculosis using an improved firefly luciferase.
Andreu N; Zelmer A; Sampson SL; Ikeh M; Bancroft GJ; Schaible UE; Wiles S; Robertson BD
J Antimicrob Chemother; 2013 Sep; 68(9):2118-27. PubMed ID: 23633686
[TBL] [Abstract][Full Text] [Related]
3. Autoluminescent Mycobacterium tuberculosis for rapid, real-time, non-invasive assessment of drug and vaccine efficacy.
Zhang T; Li SY; Nuermberger EL
PLoS One; 2012; 7(1):e29774. PubMed ID: 22253776
[TBL] [Abstract][Full Text] [Related]
4. Application of Fluorescent Protein Expressing Strains to Evaluation of Anti-Tuberculosis Therapeutic Efficacy In Vitro and In Vivo.
Kong Y; Yang D; Cirillo SL; Li S; Akin A; Francis KP; Maloney T; Cirillo JD
PLoS One; 2016; 11(3):e0149972. PubMed ID: 26934495
[TBL] [Abstract][Full Text] [Related]
5. Cell division inhibitors with efficacy equivalent to isoniazid in the acute murine Mycobacterium tuberculosis infection model.
Knudson SE; Awasthi D; Kumar K; Carreau A; Goullieux L; Lagrange S; Vermet H; Ojima I; Slayden RA
J Antimicrob Chemother; 2015 Nov; 70(11):3070-3. PubMed ID: 26245639
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.
de Knegt GJ; ten Kate MT; van Soolingen D; Aarnoutse R; Boeree MJ; Bakker-Woudenberg IA; de Steenwinkel JE
Tuberculosis (Edinb); 2014 Dec; 94(6):701-7. PubMed ID: 25621361
[TBL] [Abstract][Full Text] [Related]
7. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
8. A Novel Reporter Phage To Detect Tuberculosis and Rifampin Resistance in a High-HIV-Burden Population.
O'Donnell MR; Pym A; Jain P; Munsamy V; Wolf A; Karim F; Jacobs WR; Larsen MH
J Clin Microbiol; 2015 Jul; 53(7):2188-94. PubMed ID: 25926493
[TBL] [Abstract][Full Text] [Related]
9. A model-based analysis identifies differences in phenotypic resistance between in vitro and in vivo: implications for translational medicine within tuberculosis.
Clewe O; Faraj A; Hu Y; Coates ARM; Simonsson USH
J Pharmacokinet Pharmacodyn; 2020 Oct; 47(5):421-430. PubMed ID: 32488575
[TBL] [Abstract][Full Text] [Related]
10. Rapid, simple in vivo screen for new drugs active against Mycobacterium tuberculosis.
Nikonenko BV; Samala R; Einck L; Nacy CA
Antimicrob Agents Chemother; 2004 Dec; 48(12):4550-5. PubMed ID: 15561824
[TBL] [Abstract][Full Text] [Related]
11. Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model.
Rosenthal IM; Zhang M; Williams KN; Peloquin CA; Tyagi S; Vernon AA; Bishai WR; Chaisson RE; Grosset JH; Nuermberger EL
PLoS Med; 2007 Dec; 4(12):e344. PubMed ID: 18092886
[TBL] [Abstract][Full Text] [Related]
12. Bis-biguanide dihydrochloride inhibits intracellular replication of M. tuberculosis and controls infection in mice.
Shen H; Wang F; Zeng G; Shen L; Cheng H; Huang D; Wang R; Rong L; Chen ZW
Sci Rep; 2016 Sep; 6():32725. PubMed ID: 27601302
[TBL] [Abstract][Full Text] [Related]
13. The New Xpert MTB/RIF Ultra: Improving Detection of
Chakravorty S; Simmons AM; Rowneki M; Parmar H; Cao Y; Ryan J; Banada PP; Deshpande S; Shenai S; Gall A; Glass J; Krieswirth B; Schumacher SG; Nabeta P; Tukvadze N; Rodrigues C; Skrahina A; Tagliani E; Cirillo DM; Davidow A; Denkinger CM; Persing D; Kwiatkowski R; Jones M; Alland D
mBio; 2017 Aug; 8(4):. PubMed ID: 28851844
[TBL] [Abstract][Full Text] [Related]
14. The use of Mycobacterium tuberculosis H37Ra-infected immunocompetent mice as an in vivo model of persisters.
Kumari N; Sharma R; Ali J; Chandra G; Singh S; Krishnan MY
Tuberculosis (Edinb); 2024 Mar; 145():102479. PubMed ID: 38262199
[TBL] [Abstract][Full Text] [Related]
15. Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis.
Byrne ST; Denkin SM; Zhang Y
J Antimicrob Chemother; 2007 Feb; 59(2):313-6. PubMed ID: 17185297
[TBL] [Abstract][Full Text] [Related]
16. Preclinical testing of the nitroimidazopyran PA-824 for activity against Mycobacterium tuberculosis in a series of in vitro and in vivo models.
Lenaerts AJ; Gruppo V; Marietta KS; Johnson CM; Driscoll DK; Tompkins NM; Rose JD; Reynolds RC; Orme IM
Antimicrob Agents Chemother; 2005 Jun; 49(6):2294-301. PubMed ID: 15917524
[TBL] [Abstract][Full Text] [Related]
17. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
[TBL] [Abstract][Full Text] [Related]
18. Fluorescent Mycobacterium tuberculosis reporters: illuminating host-pathogen interactions.
MacGilvary NJ; Tan S
Pathog Dis; 2018 Apr; 76(3):. PubMed ID: 29718182
[TBL] [Abstract][Full Text] [Related]
19. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.
Kostera J; Leckie G; Tang N; Lampinen J; Szostak M; Abravaya K; Wang H
Tuberculosis (Edinb); 2016 Dec; 101():137-143. PubMed ID: 27865383
[TBL] [Abstract][Full Text] [Related]
20. Inhalable poly(lactic-co-glycolic acid) (PLGA) microparticles encapsulating all-trans-Retinoic acid (ATRA) as a host-directed, adjunctive treatment for Mycobacterium tuberculosis infection.
O'Connor G; Krishnan N; Fagan-Murphy A; Cassidy J; O'Leary S; Robertson BD; Keane J; O'Sullivan MP; Cryan SA
Eur J Pharm Biopharm; 2019 Jan; 134():153-165. PubMed ID: 30385419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
